J. JasonZhuMD

Genitourinary Oncology

Medical Oncologist, Levine Cancer Institute

Dr. Zhu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
101 E. W.T. Harris Blvd. Bldg. 5000
Suite 5500
Charlotte, NC 28262
Phone+1 704-863-6160

Fax+1 704-863-6161

My Bibliography

Pub Med Bibliography

Duke University HospitalFellowship, Hematology and Medical Oncology, 2016 - 2019
Duke University HospitalChief Residency, Internal Medicine, 2017 - 2018
Duke University HospitalResidency, Internal Medicine, 2013 - 2016
Emory University School of MedicineClass of 2013, MD, Cum Laude
Duke UniversityB.S.E., Biomedical Engineering, 2005 - 2009

PubMed

5 citations
Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients
J. Alexa Sanders, Connor Frasier, Justin T. Matulay, Nury Steuerwald, Jason Zhu
Translational Andrology and Urology. 2021-07-01
33 citations
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
Elisa Ledet, Earle F. Burgess, Alexandra O. Sokolova, Ellen Jaeger, Whitley Hatton
The Prostate. 2021-05-01
9 citations
Racial Disparities in Prostate Specific Antigen Screening and Referral to Urology in a Large, Integrated Health Care System: A Retrospective Cohort Study
Caroline Lu, Oluwaseun Adeyemi, William E. Anderson, Timothy Hetherington, David C. Slawson
The Journal of Urology. 2021-04-01

Lectures

Immune checkpoint inhibitor response in tumors with LRP1B variants.
2019 ASCO Annual Meeting - 6/1/2019
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
2019 ASCO Annual Meeting - 6/1/2019